Cargando…
Targeting one-carbon metabolism requires mTOR inhibition: a new therapeutic approach in osteosarcoma
The rate-limiting enzyme of serine biosynthesis, 3-phosphoglycerate dehydrogenase (PHGDH), contributes to rapid growth and proliferation when it is overexpressed in cancer. We recently described the metabolic adaptations that occur upon PHGDH inhibition in osteosarcoma. PHGDH inhibition causes metab...
Autores principales: | Rathore, Richa, Van Tine, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128185/ https://www.ncbi.nlm.nih.gov/pubmed/34027041 http://dx.doi.org/10.1080/23723556.2021.1902250 |
Ejemplares similares
-
Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017) -
Targeting ganglioneuromas with mTOR inhibitors
por: Tao, Ting, et al.
Publicado: (2021) -
VEGF signaling, mTOR complexes, and the endoplasmic reticulum: Towards a role of metabolic sensing in the regulation of angiogenesis
por: Karali, Evdoxia, et al.
Publicado: (2014) -
Antibody-based depletion of Foxp3+ T cells potentiates antitumor immune memory stimulated by mTOR inhibition
por: Kim, Hyung L
Publicado: (2014) -
Malignant manipulaTORs of metabolism: suppressing BCAA catabolism to enhance mTORC1 activity
por: Ericksen, Russell E., et al.
Publicado: (2019)